It's that time of the year when scribblers at Canaccord Genuity's Quest release a note with their UK M&A takeover tips - all 94 of them.
Graham Simpson who compiled this list of of potential takeover targets, writes: "UK companies continue to look materially undervalued, potentially making them takeover targets for both private equity and international corporates."..
The European-based investor group seeking to persuade the board of Aurinia Pharmaceuticals to carry out a strategic review has appointed a US lawyer to manage an action group for other investors looking to back its activist campaign.
The move comes as the investment consortium, led by the Switzerland-based MKT Tactical Fund, recently wrote a second letter to the chairman of Aurinia, George Milne Junior...
Has GlaxoSmithKline truly given up its pursuit of Aurinia Pharmaceuticals, the US-listed drug developer?
Last year Betaville Intelligence reported that GSK was one of the pharmaceutical giants circling Aurinia but now The Times is reporting the FTSE 100-listed group is looking at a different takeover target...
The Unilever might be a target for Nelson Peltz theory was first aired last summer but now it appears to be have become fact.
Indeed, hacks at the venerable Financial Times have dug a decent scoop today about Peltz building a stake after the botched £50 billion tilt GlaxoSmithKline's consumer division. Below is a link to the FT piece:..
Dominic O'Connell, a former boss during my time jobbing on The Sunday Times busines desk, appears to be suggesting something similar to Sky News's Ian "Kingy" King earlier in the week...
Well, it looks like Ian "Kingy" King is first out of the traps to highlight something little old Betaville had been ruminating on with an old City contact over a few glasses down the pub this evening.
In a piece today King, a former City editor of The Times and now business presenter at Sky News, argues Unilever may have accidently put itself in play after attempting to buy GlaxoSmithKline's consumer division for £50 billion. Below is the link:..
There is a big deal story breaking this Saturday morning from, er, The Sunday Times.
Oliver "Shahsy" Shah and Sabah Meddings have dug out a jumbo scoop about FTSE 100-listed Unilever launching a £50 billion takeover bid for GlaxoSmithKline's consumer division. Below is a link to their cracking tale:..
FTSE 100-listed GlaxoSmithKline, Switzerland-based Roche and Japan's Otsuka Pharmaceutical are all rumoured to be the large pharmaceutical companies involved in the strategic review being carried by Aurinia Pharmaceuticals, the US-listed rare disease drug developer.
People following the situation have heard speculation Goldman Sachs is advising Aurinia on the strategic review...